Traditional Chinese medicine formula particles into Zhejiang basic medical insurance

Good formula particles, into Zhejiang basic medical insurance, Yunnan pilot! The State Food and Drug Administration held a meeting to discuss the problems left over by its history ▍ formula granules, entered Zhejiang basic medical insurance recently, Zhejiang Department of human resources and social security, Zhejiang provincial health and Family Planning Commission, Zhejiang Provincial Administration of traditional Chinese medicine on the implementation of basic level of traditional Chinese medicine outpatient common diseases by disease payment reform notice (hereinafter referred to as the notice) public solicitation opinions There is a big bright spot in the traditional Chinese medicine formula particles: the notice requires all regions to formulate the corresponding disease medical insurance payment standards according to 9 kinds of common diseases in the grass-roots TCM outpatient clinics, the recommended prescription and the single post medical insurance payment reference standards, and in combination with the local actual situation, so as to include the traditional Chinese medicine formula particles within the recommended prescription range issued by the designated medical institutions into the medical insurance payment range If traditional Chinese medicine pieces are used, the original policy shall be followed (see Annex for 9 common diseases) this is another breakthrough since August 2015 when Zhejiang took TCM Hospital above level 3 (including integrated hospital of traditional Chinese and Western Medicine) as a pilot and incorporated formula granules into medical insurance ▍ good things are continuous, and good things are in pairs when Yunnan carries out the pilot of formula granules On May 22, Yunnan industry and Information Technology Commission and Yunnan food and Drug Administration jointly issued the notice on carrying out the pilot work of Yunnan Traditional Chinese medicine formula granules research, which made it clear that Yunnan Province will carry out the pilot work of traditional Chinese medicine formula granules Enterprises meeting the following four conditions need to do a good job of declaration before June 5 Enterprises within the province shall obtain the drug production license of Yunnan Province, enterprises outside the province shall sign strategic cooperation agreements with the people's Government of Yunnan Province, and have drug production enterprises that are suitable for carrying out pilot research on the standard research, production management and clinical trial of traditional Chinese medicine formula granules; pilot research enterprises shall obtain the approval of relevant departments at the provincial level; At least complete the quality standard research work of more than 300 kinds of traditional Chinese medicine formula granules; the leader of the project research should have senior professional and technical qualifications, be healthy, have strong research and organization coordination ability, and have a good foundation of early research work It's a coherent movement In April, the general office of Yunnan provincial government issued several opinions on promoting the development of Chinese Herbal Pieces industry, actively supporting the inclusion of Chinese herbal formula particles collected in Yunnan provincial standards into the national and provincial medical insurance drug catalog ▍ in the afternoon of May 22, when the director general of the State Food and Drug Administration held a meeting, Jiao Hong, the director of the State Food and drug administration, went to the Chinese society of traditional Chinese medicine to listen to experts' opinions and suggestions on the supervision of traditional Chinese medicine At the meeting, experts from clinical, scientific research and industry put forward constructive suggestions on the re evaluation of traditional Chinese medicine injection, supervision of traditional Chinese medicine decoction pieces and traditional Chinese medicine formula particles, and proper handling of historical problems such as landmark upgrading to national standard At the national level, traditional Chinese medicine granules have been quiet for some time On March 1, 2016, after the former State Food and Drug Administration issued the measures for the administration of granules of traditional Chinese medicine (Draft for comments), the official document of the national version has not been released yet ▍ current situation of dispensing granules: 10 provinces have issued pilot documents, and 1 / 3 of the provinces that enter 8 provinces and cities with medical insurance have successively issued provincial pilot documents of dispensing granules of traditional Chinese medicine According to incomplete statistics, ten provinces, including Guangdong, Zhejiang, Guangxi, Hebei and Yunnan, have issued relevant documents In terms of medical insurance, Ningxia, Yunnan, Zhejiang, Beijing, Shenzhen, Guangzhou, etc included formula granules in the local medical insurance catalogue for reimbursement, while Tianjin and Shandong, etc carried out medical insurance reimbursement according to pieces management Formula granules enjoy the policy advantages of addition and no proportion of drugs Both hospitals and enterprises have great expectations for it How to supervise, how to define this category and restart the discussion determine the direction of this market ▍ the market is growing and is expected to exceed 30 billion After all, this is a market of 11 billion, and it is still growing According to the public data, in 2017, the sales revenue of Chinese herbal formula granules reached about 11 billion yuan, an increase of more than 20% over the same period of last year Taking traditional Chinese medicine holding as an example, its traditional Chinese medicine formula granules achieved a revenue of 5.578 billion yuan in 2017, an increase of 26.46% year on year Some insiders predict that in the future, with the further liberalization of the policy and the gradual promotion of the coverage of medical insurance reimbursement, the market scale is expected to reach 30-40 billion yuan in 3-5 years It is not far from the normative policies at the national level.